» Articles » PMID: 21765605

Cyanidin-3-rutinoside Alleviates Postprandial Hyperglycemia and Its Synergism with Acarbose by Inhibition of Intestinal α-glucosidase

Overview
Specialty Biochemistry
Date 2011 Jul 19
PMID 21765605
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The inhibitory activity on intestinal α-glucosidase by cyanidin-3-rutinoside was examined in vitro and in vivo. The IC(50) values of cyanidin-3-rutinoside against intestinal maltase, and sucrase were 2,323 ± 14.8 and 250.2 ± 8.1 µM, respectively. The kinetic analysis revealed that intestinal sucrase was inhibited by cyanidin-3-rutinoside in a mixed-type manner. The synergistic inhibition also found in combination of cyanidin-3-rutinoside with acarbose against intestinal maltase and sucrase. The oral administration of cyanidin-3-rutinoside (100 and 300 mg/kg) plus maltose or sucrose to normal rats, postprandial plasma glucose was markedly suppressed at 30-90 min after loading. Furthermore, the normal rats treated with acarbose and cyanidin-3-rutinoside (30 mg/kg) showed greater reduction of postprandial plasma glucose than the group treated with acarbose alone. These results suggest that cyanidin-3-rutinoside retards absorption of carbohydrates by inhibition of α-glucosidase which may be useful as a potential inhibitor for prevention and treatment of diabetes mellitus.

Citing Articles

Antidiabetic Potential of : -Glucosidase Inhibition, Postprandial Blood Glucose Reduction, Toxicity Evaluation, and Molecular Docking.

Sangkanu S, Heemman A, Phoopha S, Pitakbut T, Udomuksorn W, Dej-Adisai S Scientifica (Cairo). 2025; 2025:6650349.

PMID: 39950148 PMC: 11824848. DOI: 10.1155/sci5/6650349.


Clinical applications and mechanism insights of natural flavonoids against type 2 diabetes mellitus.

Bouyahya A, Balahbib A, Khalid A, Makeen H, Alhazmi H, Albratty M Heliyon. 2024; 10(9):e29718.

PMID: 38694079 PMC: 11061711. DOI: 10.1016/j.heliyon.2024.e29718.


In Vitro Digestion of Peanut Skin Releases Bioactive Compounds and Increases Cancer Cell Toxicity.

Cordeiro-Massironi K, Soares-Freitas R, Sampaio G, Pinaffi-Langley A, Bridi R, de Camargo A Antioxidants (Basel). 2023; 12(7).

PMID: 37507896 PMC: 10376574. DOI: 10.3390/antiox12071356.


Orbitrap Mass Spectrometry-Based Profiling of Secondary Metabolites in Two Unexplored Species and Bioactivity Potential.

Babacan E, Zheleva-Dimitrova D, Gevrenova R, Bouyahya A, Balos M, Cakilcioglu U Plants (Basel). 2023; 12(12).

PMID: 37375878 PMC: 10305186. DOI: 10.3390/plants12122252.


Phytochemical screening, biological evaluation, anatomical, and morphological investigation of Ferula tingitana L. (Apiaceae).

Karakaya S, Yuca H, Yilmaz G, Aydin B, Tekman E, Eksi G Protoplasma. 2023; 260(6):1581-1601.

PMID: 37338647 DOI: 10.1007/s00709-023-01874-2.


References
1.
Hanefeld M, Fischer S, Schulze J, Spengler M, Wargenau M, Schollberg K . Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care. 1991; 14(8):732-7. DOI: 10.2337/diacare.14.8.732. View

2.
Raptis S, Dimitriadis G . Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers. Exp Clin Endocrinol Diabetes. 2001; 109 Suppl 2:S265-87. DOI: 10.1055/s-2001-18588. View

3.
Galvano F, La Fauci L, Vitaglione P, Fogliano V, Vanella L, Felgines C . Bioavailability, antioxidant and biological properties of the natural free-radical scavengers cyanidin and related glycosides. Ann Ist Super Sanita. 2008; 43(4):382-93. View

4.
Aymoto Hassimotto N, Genovese M, Lajolo F . Absorption and metabolism of cyanidin-3-glucoside and cyanidin-3-rutinoside extracted from wild mulberry (Morus nigra L.) in rats. Nutr Res. 2008; 28(3):198-207. DOI: 10.1016/j.nutres.2007.12.012. View

5.
Chiasson J . Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial. Endocr Pract. 2006; 12 Suppl 1:25-30. DOI: 10.4158/EP.12.S1.25. View